Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Aldeyra Therapeutics Inc. buy melinda

Start price
€7.13
27.02.18 / 50%
Target price
€7.67
27.02.18
Performance (%)
7.59%
End price
€7.67
27.02.18
Summary
This prediction ended on 27.02.18 with a price of €7.67. The BUY prediction by melinda finished with a performance of 7.59%. melinda has a follow-up prediction for Aldeyra Therapeutics Inc. where he still thinks Aldeyra Therapeutics Inc. is a Buy. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Aldeyra Therapeutics Inc. -2.419% -2.419% -50.592% -54.777%
iShares Core DAX® -0.543% 1.491% 13.638% 16.760%
iShares Nasdaq 100 -2.696% -1.235% 31.879% 45.155%
iShares Nikkei 225® -2.863% 2.491% 12.078% 7.840%
iShares S&P 500 -1.105% 0.013% 26.888% 43.056%

Comments by melinda for this prediction

In the thread Aldeyra Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 7.59%
Target price 7.667
Change
Ends at 27.02.18

Biotechnologie und medizinische SecteurRecherche



Beruf
Entwickelt Therapeutika für Augenkrankheiten

Aldeyra Therapeutics, Inc. ist ein Biotechnologie - Unternehmen.

Es konzentriert sich in erster Linie auf der Entwicklung neuer Produkte für Immun-, Entzündungs-, Waisen und andere , die als freie Aldehyde bekannt durch natürliche toxische chemische Spezies teilweise verursacht werden , zu denken.

Das Unternehmen wurde von Thomas A. Jordan und John E. Dowling August 2004 13, gegründet und ist in Lexington, MA ansässig.

Anzahl der Mitarbeiter: 11 Personen.



Prediction Buy
Perf. (%) 7.59%
Target price 7.667
Change
Ends at 27.02.18

(Zielkurs erreicht)

Current prediction by melinda for Aldeyra Therapeutics Inc.

buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.62
18.10.23
€2.00
18.10.24
119.54%
22.07.24

Stopped prediction by melinda for Aldeyra Therapeutics Inc.

buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.34
12.03.20
€5.00
04.11.21
237.61%
05.11.21

buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.51
26.05.19
€8.12
12.03.20
-64.06%
12.03.20

buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.55
12.07.18
€7.94
21.09.18
5.42%
21.09.18

buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.35
20.04.17
€4.69
01.06.17
7.71%
01.06.17

buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.56
06.02.17
€5.23
20.04.17
1.49%
20.04.17